Clinical trials employing mebendazole for the treatment of high - grade glioma patients which receive temozolomide and for recurrent / progressive pediatric brain tumors are in the recruiting phase. (oncm.org)
The scientists will analyze whether blood levels of CMV in high - grade glioma patients currently receiving standard therapies correlate with changes in blood counts, an indicator of a therapy's success or failure. (hopkinsmedicine.org)
Ultimately, the Johns Hopkins investigators hope to determine whether high - grade glioma patients should be routinely screened for CMV and if antiviral medications or treatment may have an impact on outcomes. (hopkinsmedicine.org)